Abstract Cell-free DNA (cfDNA), which is DNA released from cells into the circulation, is one
of the most promising non-invasive biomarkers in cancer. This approach could be of interest …

The process of metastasis is characterized by the shedding of tumor cells into the
bloodstream, where they are transported to other parts of the body to seed new tumors …

Circulating tumor DNA (ctDNA) is a promising biomarker for non-invasive access of tumor
dynamics. However, most existing ctDNA analysis strategies depend on costly instrument …

A highly selective, label-free sensor for the non-Hodgkin lymphoma gene, with an aM
detection limit, utilizing electrochemical impedance spectroscopy (EIS) is presented. The …

Purpose To determine the feasibility of mRNAs (C-MYC, BCL-XL, BCL-6, NF-κβ, PTEN and
AKT) in exosomes of plasma as a liquid biopsy method for monitoring and prognostic …

Circulating cell-free DNA (ccfDNA) has been shown to be associated with the clinical
characteristics and prognosis of cancer patients. Our objective was to assess whether the …

Opinion Statement It has become clear that there is immense biological heterogeneity in
diffuse large B cell lymphoma (DLBCL). Develo** technology has allowed better …

Simple Summary A liquid biopsy is a minimally invasive strategy that provides useful
information for the management of cancer patients. Cell-free DNA (cfDNA) extraction and …

Background: Follicular lymphoma (FL), an indolent non-Hodgkin lymphoma (NHL), is
generally incurable. Favourable prognosis and durable remission are crucial for FL patients …

Abstract The 2016 World Health Organisation revised classification of lymphoma has sub‐
classified well‐defined entities and added a number of provisional entities on the basis of …